191 related articles for article (PubMed ID: 19100681)
1. p53 controls prostate-derived factor/macrophage inhibitory cytokine/NSAID-activated gene expression in response to cell density, DNA damage and hypoxia through diverse mechanisms.
Kelly JA; Lucia MS; Lambert JR
Cancer Lett; 2009 May; 277(1):38-47. PubMed ID: 19100681
[TBL] [Abstract][Full Text] [Related]
2. Prostate derived factor in human prostate cancer cells: gene induction by vitamin D via a p53-dependent mechanism and inhibition of prostate cancer cell growth.
Lambert JR; Kelly JA; Shim M; Huffer WE; Nordeen SK; Baek SJ; Eling TE; Lucia MS
J Cell Physiol; 2006 Sep; 208(3):566-74. PubMed ID: 16741990
[TBL] [Abstract][Full Text] [Related]
3. Drug-induced expression of nonsteroidal anti-inflammatory drug-activated gene/macrophage inhibitory cytokine-1/prostate-derived factor, a putative tumor suppressor, inhibits tumor growth.
Martinez JM; Sali T; Okazaki R; Anna C; Hollingshead M; Hose C; Monks A; Walker NJ; Baek SJ; Eling TE
J Pharmacol Exp Ther; 2006 Aug; 318(2):899-906. PubMed ID: 16714403
[TBL] [Abstract][Full Text] [Related]
4. Differential effects of hypoxia on etoposide-induced apoptosis according to the cancer cell lines.
Cosse JP; Sermeus A; Vannuvel K; Ninane N; Raes M; Michiels C
Mol Cancer; 2007 Sep; 6():61. PubMed ID: 17894897
[TBL] [Abstract][Full Text] [Related]
5. Hypoxia down-regulates DNA double strand break repair gene expression in prostate cancer cells.
Meng AX; Jalali F; Cuddihy A; Chan N; Bindra RS; Glazer PM; Bristow RG
Radiother Oncol; 2005 Aug; 76(2):168-76. PubMed ID: 16026872
[TBL] [Abstract][Full Text] [Related]
6. ATF3 induction following DNA damage is regulated by distinct signaling pathways and over-expression of ATF3 protein suppresses cells growth.
Fan F; Jin S; Amundson SA; Tong T; Fan W; Zhao H; Zhu X; Mazzacurati L; Li X; Petrik KL; Fornace AJ; Rajasekaran B; Zhan Q
Oncogene; 2002 Oct; 21(49):7488-96. PubMed ID: 12386811
[TBL] [Abstract][Full Text] [Related]
7. The HIF1alpha-inducible pro-cell death gene BNIP3 is a novel target of SIM2s repression through cross-talk on the hypoxia response element.
Farrall AL; Whitelaw ML
Oncogene; 2009 Oct; 28(41):3671-80. PubMed ID: 19668230
[TBL] [Abstract][Full Text] [Related]
8. Distinct effects of annexin A7 and p53 on arachidonate lipoxygenation in prostate cancer cells involve 5-lipoxygenase transcription.
Torosyan Y; Dobi A; Naga S; Mezhevaya K; Glasman M; Norris C; Jiang G; Mueller G; Pollard H; Srivastava M
Cancer Res; 2006 Oct; 66(19):9609-16. PubMed ID: 17018618
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of Ca2+-independent phospholipase A2 decreases prostate cancer cell growth by p53-dependent and independent mechanisms.
Sun B; Zhang X; Talathi S; Cummings BS
J Pharmacol Exp Ther; 2008 Jul; 326(1):59-68. PubMed ID: 18441250
[TBL] [Abstract][Full Text] [Related]
10. [DNA damage induces BRCA1 distribution alteration in prostate cancer cell lines].
Wang CY; Sun SK; Fu WJ; Song T; Cai W; Gao JP; Hong BF; Wang XX; Wang H
Zhonghua Nan Ke Xue; 2008 Aug; 14(8):685-9. PubMed ID: 18817338
[TBL] [Abstract][Full Text] [Related]
11. Interferon regulatory factor 3 activates p53-dependent cell growth inhibition.
Kim TK; Lee JS; Jung JE; Oh SY; Kwak S; Jin X; Lee SY; Lee JB; Chung YG; Choi YK; You S; Kim H
Cancer Lett; 2006 Oct; 242(2):215-21. PubMed ID: 16513254
[TBL] [Abstract][Full Text] [Related]
12. Regulation of p53 expression in response to 5-fluorouracil in human cancer RKO cells.
Ju J; Schmitz JC; Song B; Kudo K; Chu E
Clin Cancer Res; 2007 Jul; 13(14):4245-51. PubMed ID: 17634554
[TBL] [Abstract][Full Text] [Related]
13. Expression of macrophage inhibitory cytokine-1 in prostate cancer bone metastases induces osteoclast activation and weight loss.
Wakchoure S; Swain TM; Hentunen TA; Bauskin AR; Brown DA; Breit SN; Vuopala KS; Harris KW; Selander KS
Prostate; 2009 May; 69(6):652-61. PubMed ID: 19152406
[TBL] [Abstract][Full Text] [Related]
14. Multiple defects in negative regulation of the PKB/Akt pathway sensitise human cancer cells to the antiproliferative effect of non-steroidal anti-inflammatory drugs.
Lincová E; Hampl A; Pernicová Z; Starsíchová A; Krcmár P; Machala M; Kozubík A; Soucek K
Biochem Pharmacol; 2009 Sep; 78(6):561-72. PubMed ID: 19433066
[TBL] [Abstract][Full Text] [Related]
15. B-MYB is required for recovery from the DNA damage-induced G2 checkpoint in p53 mutant cells.
Mannefeld M; Klassen E; Gaubatz S
Cancer Res; 2009 May; 69(9):4073-80. PubMed ID: 19383908
[TBL] [Abstract][Full Text] [Related]
16. Role for Kruppel-like factor 4 in determining the outcome of p53 response to DNA damage.
Zhou Q; Hong Y; Zhan Q; Shen Y; Liu Z
Cancer Res; 2009 Nov; 69(21):8284-92. PubMed ID: 19826046
[TBL] [Abstract][Full Text] [Related]
17. Growth differentiation factor-15: induction in liver injury through p53 and tumor necrosis factor-independent mechanisms.
Zimmers TA; Jin X; Hsiao EC; Perez EA; Pierce RH; Chavin KD; Koniaris LG
J Surg Res; 2006 Jan; 130(1):45-51. PubMed ID: 16154591
[TBL] [Abstract][Full Text] [Related]
18. Berberine inhibits p53-dependent cell growth through induction of apoptosis of prostate cancer cells.
Choi MS; Oh JH; Kim SM; Jung HY; Yoo HS; Lee YM; Moon DC; Han SB; Hong JT
Int J Oncol; 2009 May; 34(5):1221-30. PubMed ID: 19360335
[TBL] [Abstract][Full Text] [Related]
19. Induction of cullin 7 by DNA damage attenuates p53 function.
Jung P; Verdoodt B; Bailey A; Yates JR; Menssen A; Hermeking H
Proc Natl Acad Sci U S A; 2007 Jul; 104(27):11388-93. PubMed ID: 17586686
[TBL] [Abstract][Full Text] [Related]
20. Regulation of DNA damage recognition and nucleotide excision repair: another role for p53.
Ford JM
Mutat Res; 2005 Sep; 577(1-2):195-202. PubMed ID: 15927209
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
